Stefano Stuard

Dr. Stefano Stuard

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2017 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
carmine zoccalicarmine zoccali
carmine zoccali
UMUlrich Moissl
Ulrich Moissl
CCCharles Chazot
Charles Chazot
FMFrancesca Mallamaci
Francesca Mallamaci
GTGiovanni Tripepi
Giovanni Tripepi
Stefano StuardStefano Stuard
Stefano Stuard
Sustained fluid overload (FO) is considered a major cause of hypertension, heart failure, and mortality in patients with ESRD on maintenance hemodialysis. However, there has not been a cohort study investigating the relationship between chronic exposure to FO and mortality in this population. We studied the relationship of baseline and cumulative FO exposure over 1 year with mortality in 39,566 patients with incident ESRD in a large dialysis network in 26 countries using whole-body bioimpedance spectroscopy to assess fluid status. Analyses were applied across three discrete systolic BP (syst-BP) categories (160 mmHg), with nonoverhydrated patients with syst-BP=130–160 mmHg as the reference category; >200,000 FO measurements were performed over follow-up. Baseline FO value predicted excess risk of mortality across syst-BP categories (160 mmHg: HR, 1.30; 95% CI, 1.19 to 1.42; all P<0.001). However, cumulative 1-year FO exposure predicted a higher death risk (P<0.001) across all syst-BP categories (160 mmHg: HR, 1.62; 95% CI, 1.39 to 1.90). In conclusion, chronic exposure to FO in ESRD is a strong risk factor for death across discrete BP categories. Whether treatment policies that account for fluid status monitoring are preferable to policies that account solely for predialysis BP measurements remains to be tested in a clinical trial.

1 December 2018 in Kidney International
Verified
Journal Article
Closed access
ATAllison Tong
Allison Tong
BMBraden Manns
Braden Manns
AWAngela Yee Moon Wang
Angela Yee Moon Wang
BHBrenda Hemmelgarn
Brenda Hemmelgarn
DWDavid C. Wheeler
David C. Wheeler
ZBZeeshan Butt
Zeeshan Butt

1 August 2016 in Kidney International
Verified
Journal Article
Closed access
CBCarlo Barbieri
Carlo Barbieri
MMManuel Molina
Manuel Molina
PPPedro Ponce
Pedro Ponce
MTMonika Tothova
Monika Tothova
ICIsabella Cattinelli
Isabella Cattinelli
BCBernard Canaud
Bernard Canaud

29 July 1998 in Nephron
Verified
Journal Article
Closed access
PDF file
Mario BonominiMario Bonomini
Mario Bonomini
Marcella RealeMarcella Reale
Marcella Reale
PSPatrizia Santarelli
Patrizia Santarelli
Stefano StuardStefano Stuard
Stefano Stuard
NSNicola Settefrati
Nicola Settefrati
AAAlberto Albertazzi
Alberto Albertazzi
Besides cell-bound adhesion molecules, which are of fundamental importance to a large number of physiological and pathological processes, soluble forms of adhesion molecules have been detected in the circulating blood in recent years. Circulating soluble adhesion molecules appear to be biologically active, and raised levels have been reported in a variety of disorders. In the present study, we used ELISA to measure the serum levels of four soluble adhesion molecules in 23 undialyzed patients with chronic renal failure (CRF), 13 patients on continuous ambulatory peritoneal dialysis (CAPD), 17 on chronic hemodialysis (HD) and 18 healthy controls having a similar mean and distribution of ages. The investigated soluble (s) molecules included intercellular adhesion molecule 1 (sICAM-1), vascular cell adhesion molecule 1 (sVCAM-1), sE-selectin and sP-selectin. sICAM-1 was found to be elevated in patients with CRF (p < 0.05), on CAPD (p < 0.02) and HD (p < 0.0001) compared with the controls but levels did not differ between the three patient groups. The higher sVCAM-1 values found in CRF (p < 0.02), CAPD (p < 0.05) and HD (p < 0.0001) as compared to controls again failed to differentiate the three groups of patients. Soluble E-selectin was also raised in the three groups (p < 0.0001) with no difference between them. Increased sP-selectin was found in CRF (p < 0.05), CAPD (p < 0.02) and in HD patients (p < 0.0001) compared to controls, and levels in HD were significantly higher (p < 0.02) than in CRF patients. Predialysis serum molecule levels did not differ between HD patients treated with cuprophan or with polyacrylonitrile dialyzers. HD sessions with both dialyzers had no effect on sICAM-1, while a decrease (p < 0.02) in sP-selectin was found after dialysis with cuprophan. In undialyzed patients with CRF, regression analysis showed a strong linear correlation between serum creatinine and serum levels of each soluble molecule. These results demonstrate that serum levels of soluble adhesion molecules ICAM-1, VCAM-1, E-selectin and P-selectin are elevated in both undialyzed patients with CRF and patients on CAPD or HD. The elevated serum levels of these proteins probably reflect inadequate clearance as well as enhanced synthesis/release.

1 May 2003 in Angiology
Verified
Journal Article
Closed access
GBG. Belcaro
G. Belcaro
MCM.R. Cesarone
M.R. Cesarone
ARA. di Renzo
A. di Renzo
RBR. Brandolini
R. Brandolini
LCL. Coen
L. Coen
MGM. Griffin
M. Griffin
The study compared, by a prospective, randomized method, 6 treatment options: A: Sclero therapy ; B: High-dose sclerotherapy; C: Multiple ligations; D: Stab avulsion; E: Foam-sclero therapy ; F: Surgery (ligation) followed by sclerotherapy. Results were analyzed 10 years after inclusion and initial treatment. Endpoints of the study were variations in ambulatory venous pressure (AVP), refilling time (RT), presence of duplex-reflux, and number of recurrent or new incompetent venous sites. The number of patients, limbs, and treated venous segments were comparable in the 6 treatment groups, also comparable for age and sex distribution. The occur rence of new varicose veins at 5 years varied from 34% for group F (surgery + sclero) and ligation (C) to 44% for the foam + sclero group (E) and 48% for group A (dose 1 sclero). At 10 years the occurrence of new veins varied from 37% in F to 56% in A. At inclusion AVP was comparable in the different groups. At 10 years the decrease in AVP and the increase in RT (indicating decrease in reflux), was generally comparable in the different groups. Also at 10 years the number of new points of major incompetence was comparable in all treatment groups. These results indicate that, when correctly performed, all treatments may be similarly effective. "Standard," low-dose sclerotherapy appears to be less effective than high-dose sclero and foam-sclerotherapy which may obtain, in selected subjects, results comparable to surgery.

1 August 2018 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
GKGeorge A. Kaysen
George A. Kaysen
XYXiaoling Ye
Xiaoling Ye
JRJochen Raimann
Jochen Raimann
YWYuedong Wang
Yuedong Wang
ATAlice Topping
Alice Topping
PKPeter Kotanko
Peter Kotanko
George A. Kaysen, Xiaoling Ye, Jochen G. Raimann, Yuedong Wang, Alice Topping, Len A. Usvyat, Stefano Stuard, Bernard Canaud, Frank M. van der Sande, Jeroen P. Kooman, Peter Kotanko, on behalf of the Monitoring Dialysis Outcomes (MONDO) Initiative